Is Estrogen a Longevity Drug? A Glycan Perspective
|Thu. Feb. 29, 2024
UTC

No description

More videos

See more videos

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Legal obstacles to longevity biotech and how we might go about removing them?

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Tales of the Molecular Garbage Man

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Thu. Feb. 29, 2024

Targeting the Root Causes of Age-Related Diseases

Thu. Feb. 29, 2024

Is Estrogen a Longevity Drug? A Glycan Perspective | Vitalia

Legal obstacles to longevity biotech and how we might go about removing them?

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Tales of the Molecular Garbage Man

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Thu. Feb. 29, 2024

Targeting the Root Causes of Age-Related Diseases

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Is Estrogen a Longevity Drug? A Glycan PerspectiveShareDownload|Thu. Feb. 29, 2024UTC

More videos

See more videos

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Clinical Trials in Prospera

Longaevus

Legal obstacles to longevity biotech and how we might go about removing them?

Clinical Trials in Prospera

Foundation Multiomics Models: Driven by Transcriptomics

Longaevus

Tales of the Molecular Garbage Man

Non-Profits. The Longevity Pioneers

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Targeting the Root Causes of Age-Related Diseases

Legal obstacles to longevity biotech and how we might go about removing them?

Clinical Trials in Prospera

Foundation Multiomics Models: Driven by Transcriptomics

Longaevus

Tales of the Molecular Garbage Man

Non-Profits. The Longevity Pioneers

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Targeting the Root Causes of Age-Related Diseases

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Clinical Trials in Prospera

Longaevus

Is Estrogen a Longevity Drug? A Glycan Perspective
|Thu. Feb. 29, 2024
UTC